The purpose of this research study is to investigate if a personalized intervention including parts such as navigation (focus on patient outreach efforts, missed and completed encounters), personalization (individual health benefits) and compensation (value health-related costs borne by patients) will help people reduce their chances of dying from preventable causes, including heart attacks, strokes, drinking alcohol, substance abuse, HIV, and other conditions.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
87
The study intervention is composed of navigation, compensation, and personalization. Navigation refers to reducing barriers posed by fragmentation of health and social systems. Compensation refers to reimbursement of out-of-pocket expenses to offset dependent care, time costs, and travel expenditures necessary to access care for the different conditions and goals of the intervention. Personalization refers to preventative interventions that are personalized based on individual for potential benefit.
NYC H+H/Bellevue
New York, New York, United States
Change in Alcohol Use Disorders Identification Test (AUDIT) Score
10-item self-assessment of alcohol use disorders. Items are rated on a scale from 0 to 4. The total score is the sum of responses and ranges from 0-40; higher scores indicate it is more likely the patient's drinking is affecting their health and safety.
Time frame: Baseline, Month 12
Change in Alcohol Use Disorders Identification Test-Concise (AUDIT-C)
4-item self-assessment of alcohol use disorders. Items are rated on a scale from 0 to 4. The total score is the sum of responses and ranges from 0-12; higher scores indicate it is more likely the patient's drinking is affecting their health and safety.
Time frame: Baseline, Month 12
Change in National Institute on Alcohol Abuse and Alcoholism (NIAAA) single-item alcohol use screen (NIAAA-1)
The NIAAA-1 asks participants how many times in the past year they have had four or more drinks (for females) or five or more drinks (for males) in a day. The responses are 0 (never), 1 (Less than once a month), 2 (One to three times per month), 3 (One to three times per week) and 4 (More than three times per week). The total score is the item response and ranges from 0-4; higher scores indicate greater unhealthy alcohol use.
Time frame: Baseline, Month 12
Change in 2-Week Timeline Follow-Back (TLFB) for Alcohol Use
The TLFB allows participants to indicate how many drinks they have had over the previous two weeks.
Time frame: Baseline, Month 12
Change in Ethanol Glucuronide (ETG) Levels
ETG (ng/ml) will be measured via urine test.
Time frame: Baseline, Month 12
Change in Phosphatidylethanol (PeTH) Levels
PeTH (ng/ml) will be measured via blood test.
Time frame: Baseline, Month 12
Change in CDC HIV Incidence Risk Index Score
3-item assessment of HIV risk among people who inject drugs. The total score ranges from 0 to 100; higher scores indicate greater risk of HIV.
Time frame: Baseline, Month 12
Change in American Heart Association/American College of Cardiology (AHA/ACC) ASCVD Risk Calculator Score
The AHA/ACC Atherosclerotic Cardiovascular Disease (ASCVD) Risk Calculator is a questionnaire that uses responses to calculate the lifetime risk of ASCVD as a percentage (0%-100%); higher percentages indicate greater lifetime risk of ASCVD. The percentages are classified as follows: * Low-risk (\<5%) * Borderline risk (5% to 7.4%) * Intermediate risk (7.5% to 19.9%) * High risk (≥20%)
Time frame: Baseline, Month 12
Mean Systolic Blood Pressure
Time frame: Up to Month 12
Mean Diastolic Blood Pressure
Time frame: Up to Month 12
Percent Change in Participants Determined to be "High-Risk" for SUD per TAPS Screening Tool
The Tobacco, Alcohol, Prescription medication, and other Substance use (TAPS) Tool is used to assess primary care patients for tobacco, alcohol, prescription drug, and illicit substance use and problems related to their use. Based on patient responses, the tool classifies the patient risk levels as "High Risk," "Problem Use," "Undetermined Risk" and "Minimal Risk." This outcome measures the percent change in participants determined to be "High Risk" for substance abuse disorder (SUD) from baseline to Month 12.
Time frame: Baseline, Month 12
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.